Treatment of Refractory Diabetic Macular Edema With Infliximab
Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with infliximab improves macular edema
which is refractory to laser photocoagulation in patients with diabetes.